Skip to content

Efficacy of a Multimodal Brain Health Intervention for Older African Americans

Efficacy of a Technology-Based Multimodal Brain Health Intervention for Older African Americans: The SHARP Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04863378
Acronym
SHARP
Enrollment
13
Registered
2021-04-28
Start date
2022-02-01
Completion date
2023-10-01
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline, Cognitive Impairment, Mild

Keywords

social engagement, neighborhood walking, reminiscence, physical activity, African American, Mild cognitive impairment

Brief summary

This study tests the feasibility, acceptability, and efficacy of a multimodal intervention (walking, social engagement, and reminiscence), including the use of wearable digital biomarkers, for cognitively healthy and mildly cognitively impaired African Americans aged 65 and older.

Detailed description

Cognitively healthy and mildly cognitively impaired participants engage in up to 8 weeks of baseline data collection and 4-16 weeks of triadic neighborhood walking using a group tablet device to access pre-programmed 1-mile routes. GPS (Global Positioning System)-triggered historical images of local Black culture and history along the route prompt conversational reminiscence about Portland, Oregon's historically Black neighborhoods. Digital biomarker technology (a continuously worn actigraph watch and an unobtrusive under-the-mattress sleep sensor) and weekly online surveys via a study Chromebook assess feasibility, acceptability, efficacy, and health outcomes. Intermittent discussions and check-ins with participants, and observational sessions will be used to elicit participant feedback.

Interventions

BEHAVIORALWalking conversational reminiscence

Triadic walking with prompted conversational reminiscence

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
Oregon Clinical and Translational Research Institute
CollaboratorOTHER
University of California, Davis
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to 110 Years
Healthy volunteers
Yes

Inclusion criteria

for walkers: 1. Self-identified African American, 2. Age \> 65 years old 3. Reside or resided for \>10 years in Portland's historically Black neighborhoods (to be familiar with Memory Markers about this area), 4. Able to ambulate independently. 5. Meeting Cognition Criteria 1. Participants with MCI (Mild Cognitive Impairment) will meet criteria consistent with the criteria outlined by the NIA-Alzheimer's Association workgroup 2. Participants without cognitive impairment will have a Montreal Cognitive Assessment (MoCA) score \> 24 (and not meet MCI criteria). Participants' cognitive function should allow them to get to and from walk locations independently or with minimal assistance. 6. Cognitive function allows independent (or minimally assisted) travel to and from walk locations 7. In-home reliable broadband internet (for weekly online surveys). 8. Ability to read, speak, and understand English

Exclusion criteria

1. Self-reported or clinically diagnosed dementia 2. Significant disease of the central nervous system 3. Severely depressed (CES-D score \> 16), significantly symptomatic psychiatric disorder 4. Advanced cardiovascular disease that would make walking difficult, including history of congestive heart failure 5. Unstable insulin-dependent diabetes mellitus, received diagnosis Type 1 Diabetes, started insulin within past 3 months, hospitalized for hypoglycemia within past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Daily Average Steps Recorded by Actigraphy Watch24 weeksDaily steps are recorded on a continuously worn actigraphy watch (Withings), which measures 24-hour activity (gross motor activity).
Daily Average Sleep Time Recorded by an Emfit QS Sleep Sensor24 weeksEmfit QS under-the-mattress sleep sensor measured sleep-wake cycles per 24-hour period.
Weekly Health Update Survey Response Time24 weeksParticipants completed a brief health update survey every week via their home computer or phone. Response time (the time it took each participant to complete the survey) was recorded in seconds.
Pittsburgh Sleep Quality Index24 weeksThe Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire assessing sleep quality and sleep disturbances over a 1-month time period. The PQSI is composed of 19 query items, a combination of open-ended questions and Likert-type scales which are scored from 0 (no difficulty) to 3 (severe difficulty), and includes 7 sleep components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. A global score is calculated from the sum of scores for each of the seven components. Total scores range from 0 to 21, a higher score indicates more acute sleep disturbances.
Weekly Survey Completion Rate24 WeeksHealthy and mildly cognitively impaired participants completed a weekly online health update survey, receiving weekly reminders to complete it. Survey completion rates and completion times over the study's duration is another measure of cognitive change.

Countries

United States

Participant flow

Pre-assignment details

Participants of the Community Stakeholder Interviewees group are identified via a consultation between the study team and representatives from UC Davis Alzheimer's Disease Center and the AAMLO

Participants by arm

ArmCount
Cognitively Healthy Participants
Participants were Black/African American adults aged 65 or over who are cognitively healthy according to a baseline Montreal Cognitive Assessment score of 24 or higher. Participants continuously wore an actigraph watch to assess activity level. Daily sleep behavior was captured on an under-the-mattress sleep sensor. Up to 8 weeks of baseline data was collected on participants prior to starting the walking component of the intervention. After the baseline data collection period, participants continued to wear the actigraph watch and continued to sleep on the sleep sensor, and walked 4-16 weeks with their triads. Triads walked 1-mile routes, three times a week while engaging in image-prompted conversational reminiscence recorded for a digital archive. Walking routes and GPS-linked reminiscence prompts (historical images with questions) were accessed via the SHARP Walking Application via a group Android tablet device.
4
Mildly Cognitively Impaired (MCI) Participants
Participants were Black/African American adults aged 65 or over who are mildly cognitively impaired according to a baseline Montreal Cognitive Assessment score below 24. Participants continuously wore an actigraph watch to assess activity level. Daily sleep behavior was captured on an under-the-mattress sleep sensor. Up to 8 weeks of baseline data was collected on participants prior to starting the walking component of the intervention. After the baseline data collection period, participants continued to wear the actigraph watch and continued to sleep on the sleep sensor, and walked 4-16 weeks with their triads. Triads walked 1-mile routes, three times a week while engaging in image-prompted conversational reminiscence recorded for a digital archive. Walking routes and GPS-linked reminiscence prompts (historical images with questions) were accessed via the SHARP Walking Application via a group Android tablet device.
5
Community Stakeholder Interviewees
Participants were Black/African American adults aged 55 and over were individually interviewed to provide qualitative insight into salient historical landmarks and events to include in future walking routes for the Oakland area
4
Total13

Baseline characteristics

CharacteristicMildly Cognitively Impaired (MCI) ParticipantsCommunity Stakeholder IntervieweesTotalCognitively Healthy Participants
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants2 Participants11 Participants4 Participants
Age, Categorical
Between 18 and 65 years
0 Participants2 Participants2 Participants0 Participants
Age, Continuous79.2 years
STANDARD_DEVIATION 4.36
66.5 years
STANDARD_DEVIATION 7.73
72.54 years
STANDARD_DEVIATION 4.18
71.1 years
STANDARD_DEVIATION 4.64
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants4 Participants13 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
United States
5 participants4 participants13 participants4 participants
Sex: Female, Male
Female
4 Participants4 Participants11 Participants3 Participants
Sex: Female, Male
Male
1 Participants0 Participants2 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 40 / 50 / 4
other
Total, other adverse events
0 / 40 / 50 / 4
serious
Total, serious adverse events
0 / 40 / 50 / 4

Outcome results

Primary

Daily Average Sleep Time Recorded by an Emfit QS Sleep Sensor

Emfit QS under-the-mattress sleep sensor measured sleep-wake cycles per 24-hour period.

Time frame: 24 weeks

Population: Outcome measure data not collected from participants in the Community Stakeholder Interviewees group

ArmMeasureValue (MEAN)Dispersion
Cognitively Healthy WalkersDaily Average Sleep Time Recorded by an Emfit QS Sleep Sensor6.71 hours of sleep per nightStandard Deviation 1.75
Mildly Cognitively Impaired (MCI) WalkersDaily Average Sleep Time Recorded by an Emfit QS Sleep Sensor5.07 hours of sleep per nightStandard Deviation 1.84
Primary

Daily Average Steps Recorded by Actigraphy Watch

Daily steps are recorded on a continuously worn actigraphy watch (Withings), which measures 24-hour activity (gross motor activity).

Time frame: 24 weeks

Population: Outcome measure data not collected from participants in the Community Stakeholder Interviewees group

ArmMeasureValue (MEAN)Dispersion
Cognitively Healthy WalkersDaily Average Steps Recorded by Actigraphy Watch2570 daily step countStandard Deviation 1000
Mildly Cognitively Impaired (MCI) WalkersDaily Average Steps Recorded by Actigraphy Watch1140 daily step countStandard Deviation 1030
Primary

Pittsburgh Sleep Quality Index

The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire assessing sleep quality and sleep disturbances over a 1-month time period. The PQSI is composed of 19 query items, a combination of open-ended questions and Likert-type scales which are scored from 0 (no difficulty) to 3 (severe difficulty), and includes 7 sleep components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. A global score is calculated from the sum of scores for each of the seven components. Total scores range from 0 to 21, a higher score indicates more acute sleep disturbances.

Time frame: 24 weeks

Population: Outcome measure data not collected from participants in the Community stakeholder interviewees group

ArmMeasureValue (MEAN)Dispersion
Cognitively Healthy WalkersPittsburgh Sleep Quality Index7.00 score on a scaleStandard Deviation 4.55
Mildly Cognitively Impaired (MCI) WalkersPittsburgh Sleep Quality Index5.60 score on a scaleStandard Deviation 3.65
Primary

Weekly Health Update Survey Response Time

Participants completed a brief health update survey every week via their home computer or phone. Response time (the time it took each participant to complete the survey) was recorded in seconds.

Time frame: 24 weeks

Population: Outcome measure data not collected from participants in the Community Stakeholder Interview group

ArmMeasureValue (MEAN)Dispersion
Cognitively Healthy WalkersWeekly Health Update Survey Response Time195 seconds to complete weekly surveyStandard Deviation 33.2
Mildly Cognitively Impaired (MCI) WalkersWeekly Health Update Survey Response Time472 seconds to complete weekly surveyStandard Deviation 234
Primary

Weekly Survey Completion Rate

Healthy and mildly cognitively impaired participants completed a weekly online health update survey, receiving weekly reminders to complete it. Survey completion rates and completion times over the study's duration is another measure of cognitive change.

Time frame: 24 Weeks

Population: Outcome measure data not collected from participants in the Community Stakeholder Interviewees group

ArmMeasureValue (NUMBER)
Cognitively Healthy WalkersWeekly Survey Completion Rate91 percentage of survey completion
Mildly Cognitively Impaired (MCI) WalkersWeekly Survey Completion Rate60 percentage of survey completion

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026